Samantha Good

564 total citations
6 papers, 434 citations indexed

About

Samantha Good is a scholar working on Infectious Diseases, Clinical Biochemistry and Pharmacology. According to data from OpenAlex, Samantha Good has authored 6 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Clinical Biochemistry and 2 papers in Pharmacology. Recurrent topics in Samantha Good's work include Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Samantha Good is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Samantha Good collaborates with scholars based in United States, Russia and India. Samantha Good's co-authors include William O’Riordan, Greg Moeck, Hai Jiang, G. Ralph Corey, Heidi Kabler, Philip Giordano, Purvi Mehra, Ashwin Porwal, Antonio L. Pérez and Matthew A. Wikler and has published in prestigious journals such as New England Journal of Medicine, Environmental Science & Technology and Clinical Infectious Diseases.

In The Last Decade

Samantha Good

6 papers receiving 413 citations

Peers

Samantha Good

ID

CB

PHEOH

PHARM

MM

Sinikka Green United States

W. O'Riordan United States

Uzo Chukwuma United States

Ashwin Porwal India

Karen Amsler United States

Gregory E. Steinkraus United States

Cristina García de la Mària Spain

Monica Ghitan United States

Josette Behra-Miellet France

Amy A. Watters United States

Sinikka Green United States

Samantha Good

234 ×0.7

ID

130 ×0.6

CB

111 ×0.6

PHEOH

111 ×0.9

PHARM

91 ×1.1

MM

Citations per year, relative to Samantha Good Samantha Good (= 1×) peers Sinikka Green

Countries citing papers authored by Samantha Good

Since Specialization

Citations

This map shows the geographic impact of Samantha Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samantha Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samantha Good more than expected).

Fields of papers citing papers by Samantha Good

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samantha Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samantha Good. The network helps show where Samantha Good may publish in the future.

Co-authorship network of co-authors of Samantha Good

This figure shows the co-authorship network connecting the top 25 collaborators of Samantha Good. A scholar is included among the top collaborators of Samantha Good based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samantha Good. Samantha Good is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Corey, G. Ralph, Francis F. Arhin, Matthew A. Wikler, et al.. (2016). Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents. 48(5). 528–534. 28 indexed citations

2.

Corey, G. Ralph, Samantha Good, Hai Jiang, et al.. (2014). Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study. Clinical Infectious Diseases. 60(2). 254–262. 169 indexed citations

3.

Corey, G. Ralph, Heidi Kabler, Purvi Mehra, et al.. (2014). Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections. New England Journal of Medicine. 370(23). 2180–2190. 226 indexed citations

4.

Corey, Ralph, et al.. (2014). 685Time to Onset and Duration of Adverse Events in Patients with Acute Bacterial Skin and Skin Structure Infections Treated with Oritavancin – The SOLO Studies. Open Forum Infectious Diseases. 1(suppl_1). S194–S194. 1 indexed citations

5.

Corey, Ralph, Matthew A. Wikler, Greg Moeck, Hai Jiang, & Samantha Good. (2014). 1331The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI). Open Forum Infectious Diseases. 1(suppl_1). S55–S55. 2 indexed citations

6.

Smyth, Lucy J.C., et al.. (2000). Assessment of the Molecular Basis of the Proallergenic Effects of Cigarette Smoke. Environmental Science & Technology. 34(7). 1370–1374. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact